Synthesis and evaluation of 5′-modified thymidines and 5-hydroxymethyl-2′-deoxyuridines as Mycobacterium tuberculosis thymidylate kinase inhibitors

Add time:09/05/2019    Source:sciencedirect.com

We report the synthesis of 5′-modified thymidines (16, 18, 21, 23) and 5,5′-bis-substituted 2′-deoxyuridine analogues (30, 47) as inhibitors of thymidine monophosphate kinase of Mycobacterium tuberculosis (TMPKmt). These analogues were evaluated for their capacity to inhibit TMPKmt and solely two 5′-modified thymidines were found to possess moderate inhibitory activity. In addition, a feasibility study of protecting groups for the 5-CH2OH moiety of 2′-deoxyuridines is described that enables to introduce the desired 5′-modification.

We also recommend Trading Suppliers and Manufacturers of 5-(benzyloxy)-2-(hydroxymethyl)-4H-pyran-4-one (cas 15771-06-9). Pls Click Website Link as below: cas 15771-06-9 suppliers

Prev:First and novel oxidation of d-fructose by potassium iodate using [IrCl3(H2O)2OH]− complex as a homogeneous catalyst in alkaline medium
Next:Original articleDiscovery of torezolid as a novel 5-hydroxymethyl-oxazolidinone antibacterial agent)